R&D Projects

EIT-DiGinnovation

project R&D: EIT Diginovation EIT Health’s DiGinnovation Program aims to facilitate the path to reimbursement and accelerate the adoption of digital health solutions by healthcare professionals and patients. ReHub is an innovative artificial intelligence (AI)-assisted digital rehabilitation solution that improves recovery for patients with non-specific low back pain (LBP). The […]

ICEX-INNOVA

project R&D: ICEX-INNOVA | OncoReHub Project financed by ICEX España Exportación e Inversiones, E.P.E., within the framework of the Innova Invest Program, and co-financed by the European Regional Development Fund (ERDF). OncoReHub OncoReHub is an R&D project aimed at the design and development of an advanced digital oncology telerehabilitation platform

ReHubPlus

project R&D: ReHub Plus The continuation of a previous project called ReHub, a rehabilitation platform only for EMS patients. Starting from this base, new respiratory functionalities will be integrated, turning the ReHub version into an improved and transversal platform that will be able to respond to the great existing therapeutic

Retech

R&D project: Reactive Retech This initiative was launched by the State Secretariat for Digitalization in 2025 through a public call for proposals. The projects were approved in December 2025 with funding from the European Union’s Next Generation EU funds, part of the Spanish Government’s Recovery, Transformation and Resilience Plan. Reactiva

Rosia Phase II

project R&D: Rosia Phase II The ROSIA-PCP project (“Remote Rehabilitation Service for Insulated Areas – Pre-CommercialProcurement”) addresses a key health challenge: how to deliver effective rehabilitation services to people living in remote areas or with limited access to traditional centers. Within this international consortium, which includes public prosecutors in Spain,

SME

R&D project: SME Phase I Rehabilitation Hub: The World’s first Digital Recovery Therapy solution The ReHub project is an innovative digital telerehabilitation solution developed by DyCare for patients with chronic musculoskeletal disorders. This 2018 report underscores ReHub’s high quality and significant potential, highlighting its commercial impact, technological innovation, and operational

Scroll to Top